Low-Level Laser Therapy (LLLT/PBM)Photobiomodulation: Mechanisms, Clinical Benefits, Therapeutic Evidence, Safety, and Limitations
LOW-LEVEL LASER THERAPY (LLLT/PBM)
Photobiomodulation: Mechanisms, Clinical Benefits, Therapeutic Evidence, Safety, and Limitations
A Scalar Nature Medicine Evidence-Based Medical Review
By David S. Park, DAcCHM, PhD, L.Ac., Dipl. O.M.
Founder, Scalar Nature Medicine & Scalar Do Hyun Gong
Prepared September 2026
INTRODUCTION
Low-Level Laser Therapy (LLLT), now more accurately referred to as Photobiomodulation Therapy (PBMT), is a non-invasive therapeutic approach that uses selected wavelengths of visible red and near-infrared light to influence biological activity.
Unlike high-powered surgical lasers, photobiomodulation is not intended to cut, ablate, burn, or intentionally destroy tissue.
Instead, appropriately delivered light energy interacts with biological tissue and may influence cellular signaling, mitochondrial activity, inflammation, circulation, pain regulation, and tissue-repair processes.
Within Scalar Nature Medicine, photobiomodulation is understood as a modern biophysical therapeutic modality that may be integrated with acupuncture, East Asian Medicine, rehabilitation, movement, and whole-person health care.
Its clinical effectiveness depends strongly on the actual treatment parameters.
These include:
Wavelength
Power
Irradiance
Energy density
Treatment duration
Target depth
Treatment area
Pulse characteristics
Treatment frequency
Tissue condition
Therefore, PBM is not one uniform treatment.
Two machines both called “low-level lasers” may produce substantially different biological effects.
EXECUTIVE SUMMARY
Photobiomodulation uses non-ionizing visible red or near-infrared light to influence biological activity without intentionally producing tissue destruction.
The strongest established clinical role is supportive care for prevention or treatment of oral mucositis in selected oncology settings using validated protocols.
Moderate or condition-dependent evidence supports selected applications involving:
Neck pain
Knee osteoarthritis
Tendinopathy
Plantar fasciitis
Androgenetic alopecia
Promising but less established areas include:
Chronic wounds
Diabetic foot ulcers
Chemotherapy-induced peripheral neuropathy
Research is also investigating:
Depression
Traumatic brain injury
Cognitive impairment
Dementia
Stroke
Parkinson disease
Other neurological applications
These neurological and systemic applications remain investigational.
Claims that PBM universally cures cancer, regenerates every organ, reverses all aging, or treats every disease are not supported by current clinical evidence.
EVIDENCE LEVELS
RELATIVELY STRONG EVIDENCE
Clinical Area:
Oral mucositis in selected cancer-treatment settings
Interpretation:
Protocol-specific supportive care.
PBM may reduce mucositis and treatment-related oral pain.
It is not cancer treatment.
MODERATE / CONDITION-DEPENDENT EVIDENCE
Clinical Areas:
Neck pain
Knee osteoarthritis
Tendinopathy
Plantar fasciitis
Androgenetic alopecia
Interpretation:
PBM may reduce symptoms or improve function in selected patients and is generally best used as an adjunct to comprehensive care.
PROMISING BUT LIMITED EVIDENCE
Clinical Areas:
Chronic wounds
Diabetic foot ulcers
Chemotherapy-induced peripheral neuropathy
Interpretation:
Some trials show encouraging outcomes, but studies are often small or heterogeneous.
PBM should not replace standard medical treatment.
INVESTIGATIONAL APPLICATIONS
Clinical Areas:
Depression
Traumatic brain injury
Cognition
Dementia
Stroke
Parkinson disease
Interpretation:
Research demonstrates promising signals, but evidence remains insufficient for broad routine clinical claims.
UNSUPPORTED AS A GENERAL CLAIM
Cancer cure
Universal organ regeneration
Universal rejuvenation
Treatment of all diseases
These claims are not established by clinical evidence.
1. WHAT IS PHOTOBIOMODULATION?
Photobiomodulation is the therapeutic application of non-ionizing light to produce photochemical and photophysical effects within biological tissues.
PBM may be delivered using:
Low-power lasers
Low-level lasers
Red-light devices
Near-infrared devices
Light-emitting diodes (LEDs)
The term “cold laser” is commonly used but can be misleading.
PBM is generally intended to create non-ablative and predominantly nonthermal biological effects.
However, some devices may generate noticeable warmth depending on:
Power density
Treatment duration
Distance
Contact
Device design
2. WAVELENGTHS AND TISSUE PENETRATION
Different wavelengths interact differently with biological tissues.
BLUE / VIOLET LIGHT
Approximate range:
400–500 nm
Research focus:
Superficial dermatologic applications
Selected antimicrobial applications
Superficial tissue targets
Penetration is relatively limited.
RED LIGHT
Approximate range:
600–700 nm
Common research targets:
Skin
Mucosa
Superficial wounds
Hair follicles
Shallow musculoskeletal tissues
NEAR-INFRARED LIGHT
Approximate range:
780–950 nm
Common research targets:
Muscle
Tendon
Joint
Peripheral nerve
Deeper musculoskeletal tissue
Transcranial research
LONGER INFRARED WAVELENGTHS
Above approximately 1,000 nm
Effects become highly device-dependent, and thermal interactions may become increasingly relevant.
A longer wavelength is not automatically:
Better
Stronger
Safer
More therapeutic
Clinical effectiveness depends on the entire optical dose that reaches the target tissue.
3. PROPOSED BIOLOGICAL MECHANISMS
3.1 MITOCHONDRIAL AND REDOX SIGNALING
One of the most widely discussed mechanisms involves the absorption of red or near-infrared photons by intracellular chromophores.
Cytochrome-c oxidase within mitochondria has received particular attention.
Photonic stimulation may influence:
Electron transport
Mitochondrial membrane potential
ATP availability
Reactive oxygen species signaling
Cellular transcription pathways
PBM should not simply be described as “increasing cellular energy.”
Its effects appear to be regulatory and dose-dependent rather than a universal increase in ATP or metabolism.
3.2 NITRIC OXIDE AND MICROCIRCULATION
Photobiomodulation may influence nitric oxide signaling.
Nitric oxide plays important roles in:
Vascular tone
Vasodilation
Blood-flow regulation
Cell signaling
Potential effects of PBM may include:
Transient vasodilation
Changes in microcirculation
Altered tissue oxygen availability
Improved local metabolic exchange
However, improved circulation alone does not explain all reported PBM effects.
3.3 INFLAMMATION AND IMMUNE SIGNALING
PBM may influence selected inflammatory pathways.
Experimental studies suggest possible effects involving:
Inflammatory mediators
Macrophage behavior
Oxidative stress
Edema
Cell signaling
These effects may help explain why PBM is being investigated for pain, injury, and wound-related conditions.
3.4 PAIN MODULATION
PBM may influence:
Peripheral nociceptor activity
Inflammatory signaling
Local edema
Neural activity
Tissue irritability
Clinical research suggests that appropriately dosed PBM can reduce pain in selected musculoskeletal conditions.
It should nevertheless be considered part of a broader diagnosis and rehabilitation strategy.
3.5 TISSUE REPAIR
Laboratory research has reported possible effects on:
Fibroblast activity
Collagen organization
Epithelial migration
Angiogenic signaling
Muscle recovery
Neuronal survival
These findings establish biological plausibility.
They do not automatically prove clinical effectiveness for every disease.
4. DOSIMETRY: WHY MORE IS NOT NECESSARILY BETTER
One of the most important concepts in photobiomodulation is the biphasic dose response.
Too little energy may produce little or no therapeutic effect.
An appropriate dose may stimulate beneficial biological responses.
Too much energy may reduce, reverse, or obscure the desired effect.
Therefore:
MORE POWER DOES NOT AUTOMATICALLY MEAN BETTER TREATMENT.
For reproducible PBM treatment, practitioners should document:
Wavelength
Spectral bandwidth
Output power
Irradiance in mW/cm²
Energy delivered
Radiant exposure in J/cm²
Treatment area
Beam profile
Continuous or pulsed operation
Pulse frequency
Duty cycle
Contact pressure
Angle
Distance
Tissue depth
Treatment time
Session frequency
Total treatment course
ENERGY CALCULATION
Energy = Power × Time
Energy density = Energy ÷ Treatment Area
Knowing only the total wattage of a device is not sufficient to understand the biological dose.
5. CLINICAL BENEFITS AND THERAPEUTIC EVIDENCE
5.1 ORAL MUCOSITIS ASSOCIATED WITH CANCER TREATMENT
This is among the most evidence-supported applications of photobiomodulation.
In selected patients receiving:
Radiotherapy
Chemotherapy
Hematopoietic stem-cell transplantation
protocol-based PBM may help reduce:
Incidence of severe oral mucositis
Oral pain
Ulcer duration
Difficulty eating
Treatment-related oral discomfort
MASCC/ISOO clinical guidelines support specified PBM protocols in defined oncology situations.
IMPORTANT:
PBM in this context treats a complication of cancer therapy.
It does not treat the cancer itself.
5.2 NECK PAIN
Randomized controlled trials and systematic reviews have reported short-term pain reduction and functional improvement in some people with acute or chronic neck pain.
Potential clinical roles include:
Pain reduction
Improved tolerance of movement
Improved participation in rehabilitation
Adjunctive use with therapeutic exercise
The effect remains dose- and condition-dependent.
5.3 OTHER MUSCULOSKELETAL PAIN
Research has examined PBM for:
Low-back pain
Temporomandibular pain
Fibromyalgia
Postsurgical pain
Musculoskeletal injury
Results vary according to:
Diagnosis
Dosage
Treatment location
Device
Patient population
PBM should generally complement rather than replace comprehensive rehabilitation.
5.4 KNEE OSTEOARTHRITIS
Several meta-analyses suggest PBM may improve pain and disability in selected patients with knee osteoarthritis.
Results appear more favorable when:
Appropriate treatment parameters are used
The correct anatomical tissues are targeted
PBM is combined with exercise
However, not all analyses demonstrate significant benefit.
PBM should therefore be considered an adjunct to:
Strength training
Exercise
Weight management
Patient education
Medical management when indicated
5.5 TENDINOPATHY AND PLANTAR FASCIITIS
Research examining lower-extremity tendinopathy and plantar fasciitis has reported reductions in pain and disability over short- and medium-term follow-up.
However:
Progressive loading remains a foundation of tendon rehabilitation.
PBM may help reduce symptoms sufficiently to improve participation in therapeutic exercise.
5.6 EXERCISE RECOVERY AND MUSCLE PERFORMANCE
Some research suggests PBM may help reduce:
Delayed-onset muscle soreness
Perceived fatigue
Selected markers of muscle damage
and may support recovery of muscle performance.
Results depend greatly on:
Dose
Timing
Muscle group
Training status
Treatment protocol
PBM cannot replace:
Sleep
Nutrition
Hydration
Recovery time
Appropriate training design
5.7 WOUND HEALING
PBM has been investigated as an adjunctive therapy for wound healing.
Experimental and clinical research suggests potential effects involving:
Fibroblast activity
Collagen organization
Epithelial migration
Microcirculation
Inflammatory regulation
Tissue repair signaling
Clinical protocols vary substantially, however, and treatment should be individualized.
5.8 DIABETIC FOOT ULCERS
Some randomized trials and meta-analyses suggest that PBM added to standard wound care may improve:
Wound-area reduction
Healing probability
Selected wound-healing measurements
However, PBM must never replace:
Vascular assessment
Infection management
Debridement when needed
Pressure offloading
Glucose management
Appropriate dressings
Medical supervision
5.9 ANDROGENETIC ALOPECIA
Red-light and low-level-light therapies have been studied for male and female pattern hair loss.
Sham-controlled studies and meta-analyses suggest repeated PBM treatment can increase hair:
Count
Density
in some patients.
Treatment usually requires repeated exposure over months.
PBM is more biologically plausible where viable but miniaturized hair follicles remain.
It cannot regenerate hair follicles that no longer exist.
6. SKIN CARE AND COSMETIC APPLICATIONS
Photobiomodulation is increasingly incorporated into cosmetic and skin-care programs.
Potential areas of interest include:
Skin recovery
Support of tissue repair
Red-light facial treatment
Inflammation modulation
Hair-loss management
Post-procedure recovery
However, cosmetic claims require careful interpretation.
The strongest evidence reviewed in this report relates more directly to:
Androgenetic alopecia
Selected wound-healing applications
General claims that PBM:
Reverses biological age
Regenerates all facial tissues
Eliminates all wrinkles
Produces guaranteed rejuvenation
are not established by current evidence.
Within Scalar Nature Medicine, cosmetic PBM should therefore be positioned as a supportive biophysical rejuvenation modality rather than a miracle anti-aging treatment.
7. CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Small randomized and phase-II studies have investigated PBM for symptoms associated with chemotherapy-induced peripheral neuropathy.
Reported potential benefits include reductions in:
Numbness
Pain
Sensory disturbance
Functional impairment
The evidence remains developing.
PBM for these patients should be coordinated with the oncology team.
8. NEUROLOGICAL AND NEUROPSYCHIATRIC RESEARCH
Transcranial photobiomodulation is one of the most interesting emerging areas of PBM research.
Conditions under investigation include:
Depression
Persistent symptoms after traumatic brain injury
Cognitive impairment
Dementia
Stroke
Parkinson disease
Small studies and early meta-analyses have reported promising signals involving:
Mood
Attention
Memory
Sleep
Post-concussion symptoms
Cognition
However, significant limitations remain.
These include:
Small sample sizes
Different devices
Different wavelengths
Different treatment protocols
Variable skull penetration
Short follow-up periods
Possible publication bias
Therefore:
TRANSCRANIAL PBM REMAINS INVESTIGATIONAL FOR MANY NEUROLOGICAL CONDITIONS.
It should not replace established neurological or psychiatric care.
9. REPRESENTATIVE CLINICAL SUCCESSES
ONCOLOGY ORAL MUCOSITIS
Clinical signal:
Reduced severe mucositis and oral pain in selected protocols.
Interpretation:
Among the strongest clinical applications of PBM, but it is supportive oncology care rather than cancer treatment.
NECK PAIN
Clinical signal:
Pain reduction compared with sham treatment in pooled clinical trials.
Interpretation:
Generally short-term and dependent on the treatment protocol.
LOWER-EXTREMITY TENDINOPATHY
Clinical signal:
Improvement in pain and disability.
Interpretation:
Best integrated with progressive loading and rehabilitation.
PATTERN HAIR LOSS
Clinical signal:
Improved hair density or hair count following repeated treatment.
Interpretation:
Treatment is gradual and does not restore follicles that are permanently absent.
DIABETIC FOOT ULCERS
Clinical signal:
Improved healing measurements when PBM is added to standard wound care.
Interpretation:
Never a substitute for infection control, vascular care, metabolic management, and pressure reduction.
TRAUMATIC BRAIN INJURY / COGNITION
Clinical signal:
Improvements reported in selected small sham-controlled studies.
Interpretation:
Promising but not yet an established routine treatment.
CLINICAL SUCCESS MUST BE INTERPRETED RESPONSIBLY
Individual before-and-after photographs and testimonials can be useful observations.
However, they do not establish proof.
The most scientifically reliable clinical success is demonstrated through:
Randomized trials
Sham controls
Blinding
Prespecified outcomes
Clearly reported treatment parameters
Replication
Clinically meaningful follow-up
10. SAFETY
PBM is generally well tolerated when appropriate equipment and validated protocols are used.
Reported adverse effects are usually mild and temporary.
Possible reactions include:
Redness
Warmth
Tingling
Temporary symptom fluctuation
Headache
Fatigue
11. EYE SAFETY
The most important preventable hazard is inappropriate ocular exposure.
This is particularly important because near-infrared light may be invisible.
Essential precautions include:
Use wavelength-appropriate protective eyewear.
Follow the laser classification and safety instructions of the device.
Never intentionally direct the beam into the eye.
Avoid treatment directly over the eyelid unless the specific device and protocol are designed and authorized for that use.
Protect the practitioner as well as the patient when required.
12. ADDITIONAL PRECAUTIONS
Inspect:
Skin
Sensation
Applicator
Cables
Device condition
before treatment.
Exercise caution with:
Photosensitivity disorders
Photosensitizing medications
Avoid unverified treatment over a known or suspected tumor unless part of an oncology-approved treatment protocol.
Pregnancy safety has not been fully established.
Indiscriminate treatment over the pregnant uterus should be avoided.
Unexplained:
Lesions
Infection
Ischemia
Progressive neurological deficits
Suspected malignancy
require appropriate medical evaluation.
13. CANCER: A CRITICAL DISTINCTION
Photobiomodulation should never be described as a universal cancer cure.
Its strongest oncology role is currently the management of certain treatment-related adverse effects, especially oral mucositis.
Treatment close to active tumors requires individualized risk-benefit evaluation and coordination with the oncology team.
Evidence showing that PBM reduces treatment-related toxicity cannot be extrapolated to claim that PBM:
Kills cancer
Eliminates tumors
Prevents cancer recurrence
Cures malignancy
14. LASER VERSUS LED
LOW-LEVEL LASER
Optical characteristics:
Narrower beam
Higher directionality
Usually coherent at the source
Potential clinical advantage:
Precise treatment of smaller targets
Important limitation:
Coherence alone does not guarantee greater therapeutic effectiveness.
Safety:
Direct or reflected eye exposure may be hazardous.
LED-BASED PBM
Optical characteristics:
Broader illumination
More divergent light
Noncoherent output
Potential clinical advantage:
Useful for larger treatment fields.
LED devices can produce biologically meaningful PBM when wavelength and dose are appropriate.
High-intensity LED systems also require appropriate eye-safety assessment.
THE IMPORTANT QUESTION
The most clinically important question is not simply:
“Is it laser or LED?”
The important question is:
Does the correct optical dose reach the intended biological target safely and reproducibly?
15. INTEGRATION WITH SCALAR NATURE MEDICINE
Within Scalar Nature Medicine, photobiomodulation can be classified as a modern biophysical therapeutic modality.
It may be integrated with:
Acupuncture
East Asian Medicine
Manual therapy
Tuina
Movement rehabilitation
Therapeutic exercise
Scalar Do Hyun Gong
Lifestyle medicine
Conventional medical treatment
The purpose is not to claim that light cures every disorder.
The purpose is to use an appropriate physical stimulus to support a clearly defined therapeutic objective.
16. PBM AND ACUPUNCTURE
Photobiomodulation may be incorporated into acupuncture-oriented practice in several ways.
Potential applications include:
Non-invasive stimulation of painful locations
Treatment of selected acupuncture points
Support of local tissue recovery
Pain reduction before therapeutic exercise
Alternative stimulation where needle insertion is undesirable
When the term “laser acupuncture” is used, an important scientific distinction should be maintained.
Effects caused by local photobiomodulation should not automatically be attributed uniquely to acupuncture-point selection.
Both mechanisms may be investigated, but they should not be confused.
17. PBM AND REHABILITATION
PBM may be particularly useful when integrated with rehabilitation.
A practical conceptual sequence is:
ASSESS
↓
PBM
↓
PAIN REDUCTION / TISSUE SUPPORT
↓
MOVEMENT
↓
THERAPEUTIC EXERCISE
↓
STRENGTHENING
↓
FUNCTIONAL RESTORATION
In this model:
PBM does not replace rehabilitation.
PBM may help create a physiological environment in which rehabilitation becomes easier or more tolerable.
18. PBM AND SCALAR DO HYUN GONG
Scalar Do Hyun Gong emphasizes:
Movement
Breathing
Relaxation
Balance
Body awareness
Coordination
Functional cultivation
PBM may complement movement practice when clinically appropriate by supporting selected goals involving:
Pain
Muscular recovery
Tendon symptoms
Joint discomfort
Tissue recovery
However:
The machine provides a biological stimulus.
Movement restores function.
19. THE SCALAR NATURE MEDICINE INTEGRATION PRINCIPLE
The Scalar Nature Medicine approach can be expressed as:
LIGHT
+
MOVEMENT
+
ACUPUNCTURE
+
NATURAL MEDICINE
+
REHABILITATION
+
NUTRITION
+
SLEEP
+
STRESS REGULATION
+
LIFE CULTIVATION
=
WHOLE-PERSON HEALTH SUPPORT
No single modality should be expected to perform the entire healing process.
20. CLINICAL DOCUMENTATION
For reproducible clinical practice, document:
Treatment indication
Anatomical target
Acupuncture point if applicable
Wavelength
Power
Spot size
Irradiance
Energy delivered
Energy density
Contact method
Treatment time
Session frequency
Concurrent therapies
Clinical response
Adverse events
21. CLINICAL GOVERNANCE
A responsible PBM program should incorporate:
Indication-specific protocols
Appropriately maintained equipment
Operator training
Eye-safety procedures
Informed consent
Patient screening
Objective outcome measurement
Adverse-event documentation
Clinical follow-up
22. OUTCOME MEASUREMENT
Depending on the condition, useful outcomes may include:
Pain scales
Disability scales
Range of motion
Functional testing
Wound area
Standardized photographs
Hair count
Hair density
Medication use
Strength
Patient-reported function
Adverse events
Duration of benefit
23. IMMEDIATE IMPROVEMENT DOES NOT ALWAYS MEAN TISSUE REPAIR
Patients may sometimes report an immediate improvement after treatment.
This can be clinically meaningful.
However, immediate change should not automatically be interpreted as proof of structural healing.
Possible contributors include:
Pain modulation
Sensory effects
Placebo response
Natural symptom fluctuation
Measurement variability
Concurrent treatments
Longer-term improvement should be assessed through appropriate follow-up.
24. PHOTOBIOMODULATION AND REJUVENATION
Within Scalar Nature Medicine, rejuvenation is broader than cosmetic appearance.
Rejuvenation includes:
Functional capacity
Movement
Strength
Circulation
Tissue health
Recovery
Sleep
Mental vitality
Resilience
PBM may support selected components of this process.
However:
Photobiomodulation has not been scientifically established as a universal method for reversing biological aging.
It should therefore be presented as one potential component of a comprehensive rejuvenation strategy.
25. PHOTOBIOMODULATION AND “ENERGY MEDICINE”
Photobiomodulation provides an important example of the need for precision when discussing energy.
The light used in PBM is measurable physical electromagnetic energy.
Its parameters can be quantified.
These include:
Wavelength
Power
Irradiance
Energy
Treatment area
Treatment time
This should be distinguished from broader metaphysical or biofield concepts explored within Scalar Nature Medicine.
Biomedical mechanisms of PBM should first be explained using established photobiology and physiology.
That scientific clarity strengthens integrative medicine.
26. THE DOSE IS THE MEDICINE
The central PBM principle can be summarized as:
TOO LITTLE
=
Possibly ineffective
APPROPRIATE DOSE
=
Potential therapeutic biological response
TOO MUCH
=
Potentially reduced effect or unwanted biological response
Therefore:
PRECISION IS MORE IMPORTANT THAN POWER.
27. WHAT PBM DOES NOT PROVE
Current evidence does not establish that PBM universally:
Cures cancer
Treats all diseases
Regenerates every organ
Reverses biological aging
Eliminates all inflammation
Restores every damaged nerve
Replaces conventional medicine
Making these distinctions does not weaken photobiomodulation.
It strengthens its credibility.
28. WHAT PBM CAN REASONABLY OFFER
Depending on the condition and protocol, PBM may provide useful adjunctive support for:
Selected musculoskeletal pain
Neck pain
Selected osteoarthritis symptoms
Tendinopathy
Plantar fasciitis
Oral mucositis associated with cancer treatment
Selected wound-care applications
Androgenetic alopecia
Exercise recovery
Selected investigational neurological applications
The evidence differs considerably among these conditions.
29. FINAL MEDICAL ASSESSMENT
Photobiomodulation is a legitimate and biologically plausible therapeutic modality with meaningful clinical evidence in selected indications.
Its most defensible clinical roles currently include:
Protocol-specific supportive treatment for oral mucositis
and
Adjunctive management of selected musculoskeletal pain conditions.
Evidence is encouraging but less definitive for:
Chronic wounds
Diabetic foot ulcers
Androgenetic alopecia
Chemotherapy-induced peripheral neuropathy
Neurological, neurodegenerative, systemic anti-aging, organ-regeneration, and universal disease-curing applications remain investigational or unsupported.
The therapeutic result depends on:
Wavelength
Tissue penetration
Irradiance
Radiant exposure
Treatment geometry
Timing
Biological context
PBM should therefore be practiced as a precisely measured optical intervention rather than generic “healing light.”
30. SCALAR NATURE MEDICINE CLINICAL INTERPRETATION
Within Scalar Nature Medicine, photobiomodulation is best positioned as a measured light-based adjunct that may support selected therapeutic goals involving:
Pain management
Tissue recovery
Rehabilitation
Wound care
Hair-loss management
Selected supportive oncology care
Rejuvenation-oriented skin and tissue programs
Its greatest clinical value comes from combining precise photobiological stimulation with:
Accurate diagnosis
Appropriate patient selection
Acupuncture when indicated
Movement
Rehabilitation
Exercise
Nutrition
Sleep
Stress regulation
Whole-person health care
THE CENTRAL PRINCIPLE
Photobiomodulation demonstrates a fundamental Scalar Nature Medicine concept:
PHYSICAL ENERGY
↓
BIOLOGICAL SIGNAL
↓
CELLULAR RESPONSE
↓
TISSUE RESPONSE
↓
ADAPTATION
↓
FUNCTION
The light initiates the signal.
The living body performs the biological response.
CONCLUSION
Low-Level Laser Therapy, or Photobiomodulation Therapy, represents an important modern bridge between physics and biology.
Red and near-infrared light can influence cellular and tissue processes without intentionally destroying tissue.
Clinical evidence demonstrates meaningful potential in selected applications, particularly:
Oral mucositis
Musculoskeletal pain
Knee osteoarthritis
Tendinopathy
Plantar fasciitis
Pattern hair loss
Selected wound-care situations
Research continues in many other areas.
Within Scalar Nature Medicine, PBM can be integrated with acupuncture, movement, rehabilitation, natural medicine, and whole-person health care.
The most important principle is not simply:
“Use light.”
It is:
CHOOSE THE CORRECT WAVELENGTH.
DELIVER THE CORRECT DOSE.
TARGET THE CORRECT TISSUE.
MEASURE THE RESPONSE.
INTEGRATE THE TREATMENT.
And always remember:
THE DEVICE PROVIDES THE STIMULUS.
THE BODY PERFORMS THE HEALING AND REMODELING.
MEDICAL & SCIENTIFIC DISCLAIMER
This publication is intended for professional education and general health information.
It does not diagnose, prescribe, or replace individualized medical care.
Photobiomodulation parameters, indications, contraindications, and regulatory status vary according to device and clinical context.
Clinical use should follow:
Applicable scope-of-practice requirements
Manufacturer instructions
Laser and eye-safety procedures
Appropriate patient screening
Informed consent
Evidence-based clinical protocols
Serious, progressive, unexplained, oncological, vascular, neurological, infectious, or wound-related conditions require appropriate medical evaluation and referral.
Photobiomodulation should not be considered a universal cure or a replacement for necessary medical treatment.
ABOUT THE AUTHOR
David S. Park, DAcCHM, PhD, L.Ac., Dipl. O.M.
Founder of Scalar Nature Medicine and Scalar Do Hyun Gong.
His work integrates East Asian Medicine, acupuncture, natural medicine, movement, Qigong, meditation, rejuvenation, healthy aging, mind-body cultivation, biophysical therapeutic methods, and whole-person approaches to health and human development.
SELECTED REFERENCES
1. Zadik Y, et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients. Support Care Cancer. 2019.
2. Elad S, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020.
3. Cruz AR, et al. Efficacy of photobiomodulation in the treatment of oral mucositis: systematic review and meta-analysis. 2023.
4. Shen B, et al. Photobiomodulation in oral mucositis among patients with head and neck cancer: systematic review and meta-analysis. 2024.
5. Chow RT, et al. Efficacy of low-level laser therapy in the management of neck pain: systematic review and meta-analysis. Lancet. 2009.
6. Gross AR, et al. Low-level laser therapy for neck pain. Cochrane Database Syst Rev. 2013.
7. Skelly AC, et al. Noninvasive nonpharmacological treatment for chronic pain: systematic review update. 2020.
8. de Oliveira MF, et al. Low-intensity laser and LED photobiomodulation for musculoskeletal pain. 2022.
9. Stausholm MB, et al. Efficacy of LLLT on pain and disability in knee osteoarthritis. BMJ Open. 2019.
10. Rayegani SM, et al. Safety and effectiveness of LLLT in knee osteoarthritis: systematic review and meta-analysis. 2017.
11. Huang Z, et al. Effectiveness of LLLT in knee osteoarthritis: systematic review and meta-analysis. Osteoarthritis Cartilage. 2015.
12. Naterstad IF, et al. LLLT in lower-extremity tendinopathy and plantar fasciitis: systematic review and meta-analysis. BMJ Open. 2022.
13. Li S, et al. LLLT for healing diabetic foot ulcers: systematic review and meta-analysis. 2020.
14. Santos NR, et al. PBM parameters in resolution of diabetic foot ulcers: systematic review and meta-analysis. 2021.
15. Tchanque-Fossuo CN, et al. LLLT for diabetic foot ulcers: systematic review and meta-analysis. 2018.
16. Adil A, Godwin M. Effectiveness of treatments for androgenetic alopecia: systematic review and meta-analysis. J Am Acad Dermatol. 2017.
17. Liu KH, et al. Meta-analysis of PBM for androgenetic alopecia. 2019.
18. Suchonwanit P, et al. Efficacy and safety of LLLT for androgenetic alopecia: randomized sham-controlled trial. 2018.
19. Updated network meta-analysis of monotherapies for male androgenetic alopecia. 2024.
20. Argenta PA, et al. PBM for chemotherapy-induced peripheral neuropathy: randomized sham-controlled trial. 2017.
21. Teng C, et al. PBM for chemotherapy-induced peripheral neuropathy: randomized phase II trial. 2023.
22. NEUROLASER trial: PBM prevention of chemotherapy-induced peripheral neuropathy. 2022.
23. Systematic reviews of noninvasive neuromodulation for chemotherapy-induced peripheral neuropathy. 2018–2024.
24. Ji E, et al. PBM for depression: systematic review and meta-analysis of randomized trials. 2024.
25. Lee TL, et al. Transcranial PBM and cognitive outcomes: systematic review. 2023.
26. Zeng J, et al. Transcranial PBM for cognitive outcomes after traumatic brain injury. 2024.
27. Montazeri K, et al. Transcranial PBM in common brain disorders: systematic review. 2021.
28. Salehpour F, et al. Transcranial PBM and cognitive performance: systematic review and meta-analysis. 2019.
29. Lee TL, et al. Sham-controlled transcranial PBM study in traumatic brain injury. 2025.
30. U.S. Food and Drug Administration. Photobiomodulation (PBM) Devices: Premarket Notification [510(k)] Submissions—Draft Guidance.
31. U.S. Food and Drug Administration. Frequently Asked Questions About Lasers.
32. U.S. Food and Drug Administration. Laser Products and Instruments.
33. U.S. Food and Drug Administration. Low Level Laser System for Aesthetic Use—Class II Special Controls Guidance.
34. Robijns J, et al. Photobiomodulation therapy in management of cancer therapy side effects: position paper. 2022.